Clinical Trial Update: Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial comparing pulse-dose versus continuous cyclophosphamide for induction of remission in ANCA-associated vasculitis (granulomatosis wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: ANCA Associated Systemic Vasculitis, Wegener's Granulomatosis | Phase 2, Phase 3 | Status: COMPLETED